April 2020: an ambulance picks up a possible covid patient near Liège. Whether the pill really makes a difference – and thus reduces the risk of hospitalization – will be known in September or October. — © afp
The drug company Merck is investigating whether molnupiravir can prevent the first symptoms from derailing into severe covid-19. It is one of the few drugs in the pipeline to avoid hospital admissions.
Read Also
- Called budget products, reducing the blood vessels and heart May 17, 2020
- The Quirónsalud Hospitals of Andalusia renew their certification as protected areas against Covid-19 Jun 3, 2021
- University, Consulcesi: “Every year 3% aspiring doctors excluded for oversights” Aug 31, 2021
- Cancer, new discovery: here’s how to make chemotherapy more effective Aug 25, 2021
- Coronavirus The coronavirus is now spreading at young people’s parties, but the situation is not as serious as in the spr Jul 17, 2021
- Called useful and harmful properties of carrots Jul 17, 2020
- Balearics coronavirus figures for Friday, September 3 Sep 3, 2021
Maxie Eckert
Today at 11:34 AM
.
